Center for Human Genetics, Inc (Center for Human Genetics, Inc)
General information
Center for Human Genetics, Inc
Center for Human Genetics, Inc
840 Memorial Drive Suite 101
Riverside Technology Center
Cambridge
Massachusetts
United States - 02139
http://www.chginc.org/
Organization ID: 1024
Center for Human Genetics, Inc
840 Memorial Drive Suite 101
Riverside Technology Center
Cambridge
Massachusetts
United States - 02139
http://www.chginc.org/
Organization ID: 1024
Personnel
- Director: Jeff Milunsky
Phone: 617-492-7083
Fax: 617-492-7092
Email: [email protected] - Hayk Hovhannisyan, Lab Associate Director
Phone: 6174927083
Email: [email protected] - Jeff Milunsky, Lab Director
Phone: 617-492-7083
Email: [email protected]
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 1559
Gene
Gene | Submissions | Last Updated |
---|---|---|
ACSL4 | 2 | Nov 17, 2017 |
ACTA2 | 6 | Jul 17, 2018 |
ACTG2 | 6 | Jul 17, 2018 |
APC | 14 | Jul 17, 2018 |
ATM | 3 | Dec 20, 2017 |
ATRX | 3 | Dec 20, 2017 |
BRAF | 5 | Dec 20, 2017 |
C11orf65 | 1 | Dec 20, 2017 |
CDKL5 | 8 | Dec 20, 2017 |
CDKN2A | 1 | Jul 17, 2018 |
CHD7 | 19 | Dec 20, 2017 |
COL11A1 | 32 | Jul 17, 2018 |
COL11A2 | 33 | Jul 17, 2018 |
COL1A1 | 23 | Jul 17, 2018 |
COL1A2 | 25 | Jul 17, 2018 |
COL1A2-AS1 | 1 | Jul 17, 2018 |
COL2A1 | 35 | Jul 17, 2018 |
COL3A1 | 30 | Jul 17, 2018 |
COL5A1 | 43 | Jul 17, 2018 |
COL5A2 | 35 | Jul 17, 2018 |
CTRC | 2 | Dec 20, 2017 |
EDN3 | 2 | Dec 20, 2017 |
EDNRB | 6 | Dec 20, 2017 |
EDNRB-AS1 | 6 | Dec 20, 2017 |
FBN1 | 126 | Aug 17, 2018 |
FBN2 | 55 | Jul 17, 2018 |
FGD1 | 8 | Dec 20, 2017 |
FGF10 | 8 | Dec 20, 2017 |
FGFR2 | 2 | Dec 20, 2017 |
FLNA | 41 | Jul 17, 2018 |
FOXG1 | 4 | Dec 20, 2017 |
FRMPD4 | 2 | Dec 20, 2017 |
HRAS | 2 | Dec 20, 2017 |
KDM6A | 3 | Dec 20, 2017 |
KMT2D | 171 | Dec 20, 2017 |
KRAS | 1 | Dec 20, 2017 |
LOC101448202 | 4 | Dec 20, 2017 |
LOC107303340 | 3 | Dec 20, 2017 |
LOC107988032 | 1 | Dec 20, 2017 |
LOC111811965 | 3 | Dec 20, 2017 |
LOC113939944 | 2 | Dec 20, 2017 |
LOC121740638 | 9 | Dec 20, 2017 |
LOC126805814 | 1 | Jul 17, 2018 |
LOC126806529 | 1 | Dec 20, 2017 |
LOC126806791 | 1 | Jul 17, 2018 |
LOC126807501 | 2 | Dec 20, 2017 |
LOC126807619 | 1 | Dec 20, 2017 |
LOC126860403 | 1 | Dec 20, 2017 |
LOC126860794 | 2 | Jul 17, 2018 |
LOC126861339 | 1 | Dec 20, 2017 |
LOC126861520 | 3 | Dec 20, 2017 |
LOC126862124 | 1 | Dec 20, 2017 |
LOC126862586 | 1 | Dec 20, 2017 |
LOC126863207 | 5 | Dec 20, 2017 |
LOX | 1 | Dec 20, 2017 |
LRRC56 | 2 | Dec 20, 2017 |
MECP2 | 12 | Dec 20, 2017 |
MEN1 | 9 | Dec 20, 2017 |
MFAP5 | 1 | Dec 20, 2017 |
MID1 | 13 | Dec 20, 2017 |
MIR4733HG | 3 | Dec 20, 2017 |
MITF | 10 | Dec 20, 2017 |
MLH1 | 16 | Dec 20, 2017 |
MSH2 | 12 | Dec 20, 2017 |
MSH6 | 19 | Dec 20, 2017 |
MUTYH | 5 | Dec 20, 2017 |
MYH11 | 51 | May 14, 2019 |
MYLK | 37 | Jul 17, 2018 |
MYLK-AS1 | 5 | Jul 17, 2018 |
NDE1 | 26 | May 14, 2019 |
NF1 | 263 | Jul 17, 2018 |
NF2 | 12 | Dec 20, 2017 |
NOTCH1 | 64 | Jul 17, 2018 |
NSD1 | 21 | Dec 20, 2017 |
NTM | 3 | Jul 17, 2018 |
PAX3 | 29 | Jul 26, 2018 |
PCDH19 | 5 | Dec 20, 2017 |
PLP1 | 1 | Dec 20, 2017 |
POLR2F | 16 | Dec 20, 2017 |
PQBP1 | 1 | Dec 20, 2017 |
PRKG1 | 12 | Jul 17, 2018 |
PRSS1 | 3 | Dec 20, 2017 |
PTEN | 6 | Dec 20, 2017 |
PTPN11 | 9 | Dec 20, 2017 |
RAB9B | 1 | Dec 20, 2017 |
RAF1 | 1 | Dec 20, 2017 |
RET | 5 | Dec 20, 2017 |
RPS6KA3 | 8 | Dec 20, 2017 |
RS1 | 1 | Dec 20, 2017 |
SCN5A | 1 | Dec 20, 2017 |
SDHB | 10 | Dec 20, 2017 |
SDHC | 3 | Dec 20, 2017 |
SDHD | 4 | Dec 20, 2017 |
SH2D1A | 3 | Dec 20, 2017 |
SMAD3 | 6 | Jul 17, 2018 |
SOS1 | 1 | Dec 20, 2017 |
SOX10 | 16 | Dec 20, 2017 |
SPINK1 | 5 | Dec 20, 2017 |
SPRED1 | 10 | Dec 20, 2017 |
SRFBP1 | 1 | Dec 20, 2017 |
SYNGAP1 | 3 | Dec 20, 2017 |
SYNGAP1-AS1 | 2 | Dec 20, 2017 |
TCF4 | 5 | Dec 20, 2017 |
TFAP2A | 13 | Dec 20, 2017 |
TFAP2A-AS2 | 9 | Dec 20, 2017 |
TGFB2 | 6 | Jul 17, 2018 |
TGFB3 | 1 | Dec 20, 2017 |
TGFBR1 | 10 | Jul 17, 2018 |
TGFBR2 | 12 | Jul 17, 2018 |
TGFBR3 | 11 | Jul 17, 2018 |
TRB | 3 | Dec 20, 2017 |
TSC1 | 17 | Dec 20, 2017 |
TSC2 | 23 | Jul 17, 2018 |
TSR2 | 1 | Dec 20, 2017 |
VHL | 6 | Dec 20, 2017 |
ZEB2 | 8 | Dec 20, 2017 |
Condition
Testing in GTR
Disease name | Number of tests |
---|---|
46,XX testicular disorder of sex development | 2 tests |
46,XY sex reversal 1 | 2 tests |
46,XY sex reversal 3 | 1 test |
4p partial monosomy syndrome | 1 test |
5p partial monosomy syndrome | 2 tests |
Aarskog syndrome | 1 test |
Allan-Herndon-Dudley syndrome | 1 test |
Alpha thalassemia-X-linked intellectual disability syndrome | 1 test |
Aneurysm-osteoarthritis syndrome | 2 tests |
Angelman syndrome | 1 test |
Aortic aneurysm | 1 test |
Aortic aneurysm, familial thoracic 4 | 1 test |
Aortic aneurysm, familial thoracic 6 | 1 test |
Aortic aneurysm, familial thoracic 9 | 1 test |
Aortic valve disease 1 | 1 test |
Aortic valve disease 2 | 1 test |
Ashkenazi Jewish disorders | 1 test |
Autism spectrum disorder | 2 tests |
Autism, susceptibility to, X-linked 4 | 1 test |
Autosomal recessive nonsyndromic hearing loss 1A | 1 test |
Autosomal recessive nonsyndromic hearing loss 1B | 1 test |
Autosomal recessive nonsyndromic hearing loss 4 | 1 test |
Azoospermia | 1 test |
Azorean disease | 1 test |
Becker muscular dystrophy | 1 test |
Bloom syndrome | 1 test |
Borjeson-Forssman-Lehmann syndrome | 1 test |
Branchiooculofacial syndrome | 1 test |
Breast and/or ovarian cancer | 1 test |
Breast-ovarian cancer, familial, susceptibility to, 1 | 1 test |
Breast-ovarian cancer, familial, susceptibility to, 2 | 1 test |
CHARGE syndrome | 1 test |
Carcinoma of colon | 1 test |
Cardiac valvular dysplasia, X-linked | 1 test |
Cardiofaciocutaneous syndrome 1 | 2 tests |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | 1 test |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 1 test |
Charcot-Marie-Tooth disease type 1B | 1 test |
Charcot-Marie-Tooth disease type 2I | 2 tests |
Charcot-Marie-Tooth disease type 2J | 1 test |
Charcot-Marie-Tooth disease, type IA | 1 test |
Childhood apraxia of speech | 1 test |
Christianson syndrome | 1 test |
Coffin-Lowry syndrome | 1 test |
Congenital contractural arachnodactyly | 2 tests |
Corpus callosum agenesis-abnormal genitalia syndrome | 1 test |
Costello syndrome | 1 test |
Creatine transporter deficiency | 1 test |
Cystic fibrosis | 1 test |
Deafness, digenic, GJB2/GJB6 | 1 test |
Dentatorubral-pallidoluysian atrophy | 1 test |
Developmental and epileptic encephalopathy, 2 | 1 test |
Developmental and epileptic encephalopathy, 9 | 1 test |
Duchenne muscular dystrophy | 1 test |
Ehlers-Danlos syndrome | 1 test |
Ehlers-Danlos syndrome, classic type | 1 test |
Ehlers-Danlos syndrome, classic type, 1 | 1 test |
Ehlers-Danlos syndrome, type 4 | 2 tests |
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 1 test |
FG syndrome 1 | 2 tests |
Familial Mediterranean fever | 1 test |
Familial adenomatous polyposis 1 | 1 test |
Familial adenomatous polyposis 2 | 1 test |
Familial dysautonomia | 1 test |
Familial thoracic aortic aneurysm and aortic dissection | 2 tests |
Fanconi anemia complementation group C | 1 test |
Fanconi anemia complementation group N | 1 test |
Fragile X syndrome | 1 test |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | 1 test |
Gaucher disease | 1 test |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA | 1 test |
Hb SS disease | 1 test |
Hemochromatosis type 1 | 1 test |
Hereditary breast ovarian cancer syndrome | 1 test |
Hereditary cancer-predisposing syndrome | 1 test |
Hereditary factor XI deficiency disease | 1 test |
Hereditary liability to pressure palsies | 1 test |
Hereditary pancreatitis | 6 tests |
Huntington disease | 1 test |
Hypogonadotropic hypogonadism 1 with or without anosmia | 1 test |
Hypogonadotropic hypogonadism 5 with or without anosmia | 1 test |
Intellectual disability | 1 test |
Intellectual disability, X-linked 21 | 1 test |
Intellectual disability, X-linked 30 | 1 test |
Intellectual disability, X-linked 41 | 1 test |
Intellectual disability, X-linked 46 | 1 test |
Intellectual disability, X-linked 58 | 1 test |
Intellectual disability, X-linked 63 | 1 test |
Intellectual disability, X-linked 72 | 1 test |
Intellectual disability, X-linked 88 | 1 test |
Intellectual disability, X-linked 89 | 1 test |
Intellectual disability, X-linked 9 | 1 test |
Intellectual disability, X-linked 90 | 1 test |
Intellectual disability, autosomal dominant 5 | 1 test |
Intellectual disability-severe speech delay-mild dysmorphism syndrome | 1 test |
Kabuki syndrome 1 | 1 test |
Kennedy disease | 1 test |
LEOPARD syndrome 1 | 1 test |
LEOPARD syndrome 2 | 1 test |
LEOPARD syndrome 3 | 1 test |
Leber optic atrophy | 1 test |
Legius syndrome | 1 test |
Levy-Hollister syndrome | 3 tests |
Loeys-Dietz syndrome | 4 tests |
Loeys-Dietz syndrome 1 | 2 tests |
Loeys-Dietz syndrome 2 | 2 tests |
Loeys-Dietz syndrome 4 | 1 test |
Lynch syndrome | 1 test |
Lynch syndrome 8 | 1 test |
MELAS syndrome | 1 test |
MERRF syndrome | 1 test |
MTHFR THERMOLABILE POLYMORPHISM | 1 test |
Macrocephaly and epileptic encephalopathy | 1 test |
Macrocephaly-autism syndrome | 1 test |
Maple syrup urine disease type 1B | 1 test |
Marfan syndrome | 2 tests |
Melanoma, cutaneous malignant, susceptibility to, 2 | 1 test |
Microdeletion / Duplication Syndromes, Absence of Heterozygosity, Aneuploidy | 1 test |
Mismatch repair cancer syndrome 1 | 3 tests |
Mitochondrial DNA-Associated Leigh Syndrome and NARP | 1 test |
Mitochondrial disease | 1 test |
Mitochondrial non-syndromic sensorineural hearing loss | 1 test |
Mondini defect | 1 test |
Mowat-Wilson syndrome | 1 test |
Mucolipidosis type IV | 1 test |
Multiple endocrine neoplasia, type 1 | 1 test |
Multiple endocrine neoplasia, type 2 | 1 test |
Neurofibromatosis, type 1 | 1 test |
Neurofibromatosis, type 2 | 1 test |
Neurofibromatosis-Noonan syndrome | 1 test |
Noonan syndrome | 1 test |
Noonan syndrome 1 | 1 test |
Noonan syndrome 3 | 1 test |
Noonan syndrome 4 | 1 test |
Noonan syndrome 5 | 1 test |
Noonan syndrome 6 | 1 test |
Noonan syndrome-like disorder with loose anagen hair 1 | 1 test |
Osteogenesis imperfecta type 1, mild | 1 test |
Osteogenesis imperfecta type 2, thin-bone | 1 test |
Osteogenesis imperfecta type I | 1 test |
Osteogenesis imperfecta, type III/IV | 1 test |
Otospondylomegaepiphyseal dysplasia, autosomal dominant | 2 tests |
PTEN hamartoma tumor syndrome | 1 test |
Palmoplantar keratoderma-deafness syndrome | 1 test |
Paragangliomas 1 | 1 test |
Paragangliomas 3 | 1 test |
Paragangliomas 4 | 1 test |
Paroxysmal extreme pain disorder | 1 test |
Partington syndrome | 1 test |
Pelizaeus-Merzbacher disease | 1 test |
Pendred syndrome | 1 test |
Phelan-McDermid syndrome | 2 tests |
Phenylketonuria | 1 test |
Pitt-Hopkins syndrome | 1 test |
Pitt-Hopkins-like syndrome 2 | 1 test |
Prader-Willi syndrome | 1 test |
Pregnancy loss, recurrent, 4 | 1 test |
Primary erythromelalgia | 1 test |
Renpenning syndrome | 1 test |
Rett syndrome | 1 test |
Rett syndrome, congenital variant | 1 test |
Severe myoclonic epilepsy in infancy | 1 test |
Sickle cell-hemoglobin C disease | 1 test |
Small fiber neuropathy | 1 test |
Smith-Lemli-Opitz syndrome | 1 test |
Smith-Magenis syndrome | 2 tests |
Sotos syndrome | 1 test |
Spermatogenic failure 4 | 2 tests |
Spermatogenic failure, Y-linked, 2 | 1 test |
Sphingomyelin/cholesterol lipidosis | 1 test |
Spinal muscular atrophy | 1 test |
Spinocerebellar ataxia 7 | 1 test |
Spinocerebellar ataxia type 1 | 1 test |
Spinocerebellar ataxia type 10 | 1 test |
Spinocerebellar ataxia type 12 | 1 test |
Spinocerebellar ataxia type 17 | 1 test |
Spinocerebellar ataxia type 2 | 1 test |
Spinocerebellar ataxia type 6 | 1 test |
Spinocerebellar ataxia type 8 | 1 test |
Spongy degeneration of central nervous system | 1 test |
Stickler syndrome type 1 | 2 tests |
Stickler syndrome type 2 | 2 tests |
Syndromic X-linked intellectual disability Claes-Jensen type | 1 test |
Syndromic X-linked intellectual disability Hedera type | 1 test |
Syndromic X-linked intellectual disability Lubs type | 1 test |
Tay-Sachs disease | 1 test |
Thrombophilia due to activated protein C resistance | 1 test |
Thrombophilia due to thrombin defect | 1 test |
Tuberous sclerosis 1 | 1 test |
Tuberous sclerosis 2 | 1 test |
Type II Collagenopathies | 1 test |
Vas deferens, congenital bilateral aplasia of, X-linked | 1 test |
Velocardiofacial syndrome | 1 test |
Visceral myopathy 1 | 1 test |
Visceral neuropathy, familial, 3, autosomal dominant | 1 test |
Von Hippel-Lindau syndrome | 1 test |
Waardenburg syndrome type 1 | 1 test |
Waardenburg syndrome type 2A | 1 test |
Waardenburg syndrome type 2E | 1 test |
Waardenburg syndrome type 4A | 1 test |
Waardenburg syndrome type 4B | 1 test |
Waardenburg syndrome type 4C | 1 test |
West syndrome | 1 test |
Williams syndrome | 1 test |
Wilson disease | 1 test |
X-linked Opitz G/BBB syndrome | 1 test |
X-linked ichthyosis with steryl-sulfatase deficiency | 1 test |
X-linked intellectual disability-cerebellar hypoplasia syndrome | 1 test |
X-linked lissencephaly with abnormal genitalia | 1 test |
X-linked lymphoproliferative disease due to SH2D1A deficiency | 1 test |
Y chromosome-related disorders | 1 test |